Tag Archives: Harvard University

Time for a Complete Reset in Alzheimer’s Disease / Dementia Drugs Research: Never Too Late? (BBC News / Brain / NHS Digital)

Posted on May 1, 2019 by Dementia and Elderly Care News

Summary A new type of dementia, previously misdiagnosed as Alzheimer’s Disease, has been discovered to be prevalent in the oldest of old persons. Perhaps a third of elderly people earlier thought to have Alzheimer’s Disease may have had Limbic-predominant age-related … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Amnestic MCI, Australia, Austria, Bazian, BBC Health News, Behind the Headlines, Brain (Journal), Central Clinical School Faculty of Medicine and Health (Sydney Australia), Clinical and Neurocognitive Features of LATE, Consensus Guidelines for LATE-NC Staging, Consensus Proposed LATE-NC TDP-43 Stages, Dementia-Related Misdiagnosis, Differential Diagnosis, Drug Trials, Drug Trials Failure Rate, Emory University (Atlanta), FTLD-TDP: Frontotemporal Lobar Degeneration With TDP-43 Proteinopathy, Harvard University, Hippocampal Atrophy, Illinois Institute of Technology, Institute of Neurology: Medical University of Vienna, Japan, LATE Biomarkers, LATE Neuropathological Change (LATE-NC), LATE Working Group, Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE), Mayo Clinic (Jacksonville), Mayo Clinic: Rochester, Medical University of Vienna, Misdiagnosis, Misdiagnosis (Potential), Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuropathology, Neuropathology in FTLD-tau and FTLD-TDP, Newcastle University, NHS Digital (Formerly NHS Choices), Oldest Old, Oldest Old Age, Oldest People With Dementia, Prevalence of Dementia in Oldest Old, Public Health Impact of LATE, Recommendations for Routine Autopsy Evaluation and Classification of LATE-NC, Rush University Medical Center, Stanford University, Subtypes of Dementia, Sweden, TDP-43 Protein, TDP-43 Proteinopathy, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, United States, University of California, University of Cambridge, University of Kentucky, University of Minnesota, University of Pennsylvania, University of Southern California, University of Sydney Brain and Mind Centre, University of Texas Southwestern Medical Center, University of Washington, Uppsala University, USA | Leave a comment

Probiotics For the Alleviation of Symptoms in Advanced Alzheimer’s Disease? (NHS Choices / Frontiers in Aging Neuroscience / BioResearch Open Access)

Posted on November 13, 2016 by Dementia and Elderly Care News

Summary Iranian researchers appear to have discovered minor improvements in the symptoms of elderly people with severe Alzheimer’s Disease, associated with the regular consumption of probiotic drinks. The effects of probiotics on biomarkers for inflammation and metabolism were also investigated. … Continue reading →

Posted in For Researchers (mostly), In the News, International, Management of Condition, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Nutrition, Quick Insights, Universal Interest | Tagged Advanced Dental Associates of New England (Massachusetts), Association Between Gut Health and Brain Function, Bazian, Behind the Headlines, Bifidobacterium bifidum, Biomarkers, Biomarkers for Inflammation and Metabolism, BioResearch Open Access (Journal), Boston University, Boston University School of Medicine, Cancer Research Center: Boston University School of Medicine, Consulate General of Greece in Boston (Massachusetts), Department of Anatomy: Boston University School of Medicine, Department of Chemistry: McGill University, Department of Health Sciences: Boston University, Department of Medicine: Boston University School of Medicine, Department of Neurology: Kashan University of Medical Sciences, Department of Pharmaceutical Chemistry: University of California San Francisco, Dietary Interventions, Dietary Supplements, Double-Blind Randomised Controlled Trials, Frontiers in Aging Neuroscience, Harvard University, hs-CRP, Improving Cognitive Functioning, Iran, Kashan University of Medical Sciences (Iran), Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus fermentum, Markers of Insulin Metabolism, McGill University, MDA, Micro Biota-Gut-Brain Axis, Microbiota-Induced Epigenetics, Mini Mental State Examination (MMSE), PhenoMatriX Inc. (Boston Massachusetts), Physiology Research Center: Kashan University of Medical Sciences, Probiotic Drinks, Probiotic Milk, Probiotic Supplementation, Probiotic Supplementation and Cognitive Function Alzheimer's Disease, Probiotic Supplementation and Metabolic Status in Alzheimer's Disease, Probiotic Supplements and Cognitive Function in Advanced Alzheimer's Disease, Probiotic Treatments, Probiotics, Probiotics in Advanced Alzheimer’s Disease, Randomised Controlled Trials: Appraisal, Research Center for Biochemistry and Nutrition in Metabolic Diseases: Kashan University of Medical Sciences, School of Medicine: Kashan University of Medical Sciences, School of Pharmacy: University of California San Francisco, Triglycerides Levels, University of California San Francisco, Weatherhead Center for International Affairs: Harvard University, Yoghurt | Leave a comment

Hospital Re-Admission Risks Alter Over Time After Discharge? (Nursing Times / Annals of Internal Medicine)

Posted on June 5, 2015 by Dementia and Elderly Care News

Summary The risk factors for hospital re-admissions may change over a 30-day period following discharge from hospital, according to US research. There appears to be two distinct phases of re-admission risk; one up to eight days and one up to … Continue reading →

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Person-Centred Care, Quick Insights, Statistics, Universal Interest | Tagged Acute Care, Acute Hospital Care, Acute Hospitals, Annals of Internal Medicine, Avoidable Acute Hospital Admission in Older People, Avoidable Hospital Admissions, Early Versus Late Readmissions, Emergency Readmissions, Harvard Catalyst, Harvard University, Health Resources and Services Administration: National Institute on Aging, Hospital Re-Admission Risks, Hospital Re-Admission Risks: Time After Discharge, Hospital Re-Admission Risks: Time of Day at Discharge, Hospital Readmission Risk Factors, National Institute on Aging, National Institutes of Health, Nursing Times, Readmissions, Reducing Early Hospital Readmissions, United States, USA | Leave a comment

UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)

Posted on August 1, 2014 by Dementia and Elderly Care News

Summary A revolution in medicine is in progress at research centres across the UK, based on unlocking the genetic bases of cancer and other diseases. The UK could become a world leader in genetic research, targeted therapies and personalised medicine. … Continue reading →

Exposure of Aged Mice to Young Blood Plasma Improves Age-Related Cognitive Impairment? (BBC News / NHS Choices / Nature Medicine / Science)

Posted on May 6, 2014 by Dementia and Elderly Care News

Summary Researchers at Stanford University believe they might have discovered a novel method of slowing, or even reversing, a range of ageing processes (mental and physical). Their work, based on mice so far, involved injecting the blood of young mice … Continue reading →

Posted in Animal Studies, BBC News, For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged AfaSci Research Laboratory: California, Age and Ageing, Age-Related Cognitive Impairment, Age-Related Neurodegenerative and Neurovascular Diseases, Aged Mice: Exposure to Young Blood Plasma, Ageing, BBC Health News, Behind the Headlines, Blood Plasma, Blood Transfusions, Brigham and Women's Hospital: Boston, Cardiovascular Division: Brigham and Women's Hospital, Cellular Ageing, Center for Systems Biology and Department of Radiology: Massachusetts General Hospital, Center for Tissue Regeneration Repair and Restoration: VA Palo Alto Health Care System, Cognitive Decline, Cognitive Decline Studies, Cognitive Impairment, Contextual Fear Conditioning, Critical Appraisals, Department of Anatomy: University of California San Francisco, Department of Neurology and Neurological Sciences: Stanford University School of Medicine, Department of Stem Cell and Regenerative Biology: Harvard University, Developmental and Stem Cell Biology Graduate Program: University of California San Francisco, Disease-Modifying Therapies for Dementia, Dr Tony Wyss-Coray: Stanford University School of Medicine, Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research: San Francisco, GDF11, Harvard Medical School, Harvard Stem Cell Institute, Harvard University, Hippocampus, Hippocampus-Based Cognitive Processes, Hippocampus-Dependent Memory Deficits, Howard Hughes Medical Institute, Joslin Diabetes Center and the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, Late-Life Cognitive Decline, Massachusetts General Hospital, Mice, Nature Medicine, Neurodegeneration, Neurodegenerative Disease Research, Neurogenesis, Neurogenic Rejuvenation of the Aging Mouse Brain (Blood Plasma), Neuroscience Graduate Program: Stanford University School of Medicine, Rejuvenation of Synaptic Plasticity, Rejuvenation of the Aging Mouse Brain (Blood Plasma), Spatial Learning and Memory, Stanford University School of Medicine, Stanford [California], Synaptic Plasticity, Translational Research, United States, University of California San Francisco, USA, VA Palo Alto Health Care System, Vascular and Neurogenic Rejuvenation, Vascular Rejuvenation of the Aging Mouse Brain (Blood Plasma), Young Blood (Rejuvenating Effects) | Leave a comment

Tag Archives: Harvard University

Probiotics For the Alleviation of Symptoms in Advanced Alzheimer’s Disease? (NHS Choices / Frontiers in Aging Neuroscience / BioResearch Open Access)

UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites